Fip clinical trials 2021. FIP CLINICAL TRIAL REPORT (Part I) : Post 30 days oral treatment report. The study’s results may provide strong evidence to support the use of doxycycline in future clinical trials for treating FIP as part of a possible combination therapy, which will be ultimately necessary to combat FIP. Oct 13, 2021 ยท The goal of this clinical trial report is to examine the safety and efficacy of GS441524 oral capsules by CURE FIP™ for the treatment of cats with various types of naturally acquired feline infectious peritonitis (FIP). The aim of this study was to evaluate efficacy and toxicity of the multi-component drug Xraphconn ® in vitro and as oral treatment in cats with spontaneous FIP by examining survival rate, development of clinical and laboratory parameters, viral loads, anti-FCoV antibodies, and adverse effects. This study will therefore seek to determine if oral administration of the immune stimulant will cause a faster resolution of clinical signs and bloodwork abnormalities and lower rate of FIP relapse post treatment. Our articles cover a wide range of topics, including breakthrough studies, clinical trials, veterinary perspectives, and news updates related to FIP. The goal of this clinical trial report is to examine the safety and efficacy of GS441524 oral capsules by CURE FIP™ for the treatment of cat. Feline Infectious Peritonitis Therapeutics/Clinical Trials Team Click here to see our current FIP trials that are recruiting new patients! Stay informed about the latest developments in FIP research, treatment options, and advancements in the understanding of this complex disease. shrwqywd cgavh hzxq knpuwl emqjf wzczuv skfo lpxv wsvwzy yiq